1. Tunstall-Pedoe H. Preventing Chronic Diseases. A Vital Investment: WHO Global Report. Geneva: World Health Organization, 2005. pp 200. CHF 30.00. ISBN 92 4 1563001. Also published on
http://www. who. int/chp/chronic_disease_report/en. Oxford University Press; 2006.
2. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes research and clinical practice. 2011;94(3):311-21.
3. Schram MT, Baan CA, Pouwer F. Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Current diabetes reviews. 2009;5(2):112-9.
4. Saltiel AR. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell. 2001;104(4):517-29.
5. Cherrington AD. Control of glucose uptake and release by the liver in vivo. Diabetes. 1999;48(5):1198.
6. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature. 2001;413(6852):131.
7. O'Brien RM, Granner DK. Regulation of gene expression by insulin. Physiological reviews. 1996;76(4):1109-61.
8. Hirota K, Sakamaki J-i, Ishida J, Shimamoto Y, Nishihara S, Kodama N, et al. A combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding. Journal of Biological Chemistry. 2008;283(47):32432-41.
9. Nie Y, Erion DM, Yuan Z, Dietrich M, Shulman GI, Horvath TL, et al. STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nature cell biology. 2009;11(4):492.
10.Rodgers JT, Lerin C, Gerhart-Hines Z, Puigserver P. Metabolic adaptations through the PGC‐1α and SIRT1 pathways. FEBS letters. 2008;582(1):46-53.
11.Sladek FM, Zhong W, Lai E, Darnell J. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes & development. 1990;4(12b):2353-65.
12.Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, et al. Control of pancreas and liver gene expression by HNF transcription factors. Science. 2004;303(5662):1378-81.
13.Hirota K, Daitoku H, Matsuzaki H, Araya N, Yamagata K, Asada S, et al. Hepatocyte nuclear factor-4 is a novel downstream target of insulin via FKHR as a signal-regulated transcriptional inhibitor. Journal of Biological Chemistry. 2003;278(15):13056-60.
14.Group DPPR. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England journal of medicine. 2002;346(6):393-403.
15.De Souza C, Araujo E, Prada P, Saad M, Boschero A, Velloso L. Short-term inhibition of peroxisome proliferator-activated receptor-γ coactivator-1α expression reverses diet-induced diabetes mellitus and hepatic steatosis in mice. Diabetologia. 2005;48(9):1860-71.
16.Luciano E, Carneiro EM, Carvalho C, Carvalheira J, Peres SB, Reis M, et al. Endurance training improves responsiveness to insulin and modulates insulin signal transduction through the phosphatidylinositol 3-kinase/Akt-1 pathway. European Journal of Endocrinology. 2002;147(1):149-57.
17.De Souza CT, Frederico MJ, Da Luz G, Cintra DE, Ropelle ER, Pauli JR, et al. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF‐4α pathway in insulin resistant mice. The Journal of physiology. 2010;588(12):2239-53.
18.Shirwaikar A, Rajendran K, Kumar CD, Bodla R. Antidiabetic activity of aqueous leaf extract of Annona squamosa in streptozotocin–nicotinamide type 2 diabetic rats. Journal of ethnopharmacology. 2004;91(1):171-5.
19.Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, et al. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 1998;47(2):224-9.
20.Eizadi M, Ravasi AA, Soori R, Baesi K, Choubineh S. Effect of three months aerobic training on TCF7L2 expression in pancreatic tissue in type 2 diabetes rats induced by streptozotocin-nicotinamide. Fiyz̤. 2017;21(1):1-8.
21.Barthel A, Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. American Journal of Physiology-Endocrinology And Metabolism. 2003;285(4):E685-E92.
22.Wiernsperger NF, Bailey CJ. The antihyperglycaemic effect of metformin. Drugs. 1999;58(1):31-9.
23.Salehi OR, Hosseini SA. The effects of endurance trainings on serum BDNF and insulin levels in Streptozotocin-induced diabetic rats. Shefaye Khatam. 2017; 5(2): 52-61.
24.Stephanie-May R, John WS, Tuomo R, Claude B, Marie-Claude V, Louis P. Interaction between HNF4A polymorphisms and physical activity in relation to type 2 diabetes-related traits: results from the Quebec Family Study. diabetes research and clinical practice. 2009;84(3):211-8.
25.Hoene M, Lehmann R, Hennige AM, Pohl AK, Häring HU, Schleicher ED, et al. Acute regulation of metabolic genes and insulin receptor substrates in the liver of mice by one single bout of treadmill exercise. The Journal of physiology. 2009;587(1):241-52.
26.Crespilho DM, de Almeida Leme JAC, de Mello MAR, Luciano E. Effects of physical training on the immune system in diabetic rats. International journal of diabetes in developing countries. 2010;30(1):33.
27.Gomes RJ, de Oliveira CAM, Ribeiro C, Mota CSdA, Moura LP, Tognoli LMMC, et al. Effects of exercise training on hippocampus concentrations of insulin and IGF‐1 in diabetic rats. Hippocampus. 2009;19(10):981-7.
28.Hosseini S, Nikbakht H, Azarbayjani M. The Effect of Resistance Training on Glycemic Indexes of Streptozotocin Induced Diabetic Rats. Physical Education and Sport Science Quarterly. 2011;2(2):42-8.
29.Rawal S, Huang H, Novikova L, Hamedi T, Smirnova I, Stehno‐Bittel L. Effects of exercise on pancreatic islets in zucker diabetic fatty rats. J Diabetes Metab S. 2013;10.
30.Ramazani N, Gaiini A, CHoobineh S, Kordi M, Baesi K. The Effect of resistance training on serum levels of RBP-4 and insulin resistance index in type 2 diabetic male rats. Journal of North Khorasan University of Medical sciences. 2017;9(2):157-47.
31.Hosseini S, Zar A, Kheirdeh M, Arayesh O. Effect of endurance training on vaspine and glycemic indexes in diabetic rats. Qom Univ Med Sci J. 2017;10(11):17-24.
32.Madsen SM, Thorup AC, Overgaard K, Jeppesen PB. High intensity interval training improves glycaemic control and pancreatic β cell function of type 2 diabetes patients. PLoS One. 2015;10(8):e0133286.
33.Chakravarty K, Wu S-Y, Chiang C-M, Samols D, Hanson RW. SREBP-1c and Sp1 interact to regulate transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) in the liver. Journal of Biological Chemistry. 2004;279(15):15385-95.
34.Yamamoto T, Shimano H, Nakagawa Y, Ide T, Yahagi N, Matsuzaka T, et al. SREBP-1 interacts with hepatocyte nuclear factor-4α and interferes with PGC-1 recruitment to suppress hepatic gluconeogenic genes. Journal of Biological Chemistry. 2004;279(13):12027-35.
35.Rhee J, Inoue Y, Yoon JC, Puigserver P, Fan M, Gonzalez FJ, et al. Regulation of hepatic fasting response by PPARγ coactivator-1α (PGC-1): requirement for hepatocyte nuclear factor 4α in gluconeogenesis. Proceedings of the national academy of sciences. 2003;100(7):4012-7.
36.Wang H, Maechler P, Antinozzi PA, Hagenfeldt KA, Wollheim CB. Hepatocyte nuclear factor 4α regulates the expression of pancreatic β-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion. Journal of Biological Chemistry. 2000;275(46):35953-9.